ArticlePloS one2014
Novel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of action.
Odile E Levy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it